Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001829126-22-013532
Filing Date
2022-06-14
Accepted
2022-06-14 16:43:29
Documents
57
Period of Report
2022-04-30

Document Format Files

Seq Description Document Type Size
1 10-Q organicellregen_10q.htm   iXBRL 10-Q 832590
2 EXHIBIT 31.1 organicellregen_ex31-1.htm EX-31.1 17058
3 EXHIBIT 31.2 organicellregen_ex31-2.htm EX-31.2 16619
4 EXHIBIT 32.1 organicellregen_ex32-1.htm EX-32.1 6112
5 EXHIBIT 32.2 organicellregen_ex32-2.htm EX-32.2 6601
  Complete submission text file 0001829126-22-013532.txt   4516389

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE ocel-20220430.xsd EX-101.SCH 39946
7 XBRL CALCULATION FILE ocel-20220430_cal.xml EX-101.CAL 41980
8 XBRL DEFINITION FILE ocel-20220430_def.xml EX-101.DEF 139638
9 XBRL LABEL FILE ocel-20220430_lab.xml EX-101.LAB 279290
10 XBRL PRESENTATION FILE ocel-20220430_pre.xml EX-101.PRE 234684
51 EXTRACTED XBRL INSTANCE DOCUMENT organicellregen_10q_htm.xml XML 681727
Mailing Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140
Business Address 4045 SHERIDAN AVENUE SUITE 239 MIAMI FL 33140 888-963-7881
Organicell Regenerative Medicine, Inc. (Filer) CIK: 0001557376 (see all company filings)

EIN.: 474180540 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-Q | Act: 34 | File No.: 000-55008 | Film No.: 221015393
SIC: 3790 Miscellaneous Transportation Equipment